VAGINAL IMMUNITY ROLE OF ENDOGENOUS/EXOGENOUS AGENTS
内源性/外源性物质的阴道免疫作用
基本信息
- 批准号:2403521
- 负责人:
- 金额:$ 16.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-01 至 1999-08-31
- 项目状态:已结题
- 来源:
- 关键词:B lymphocyte antibody formation antifungal agents biopsy cellular immunity contraceptives cytokine enzyme linked immunosorbent assay estrogens female genital secretion hormone regulation /control mechanism human subject humoral immunity immunocytochemistry menopause menstrual cycle mucosal immunity pregnancy spermicide vagina vagina disorder
项目摘要
The immune system of the female genital tract comprises the components of
mucosal (local) and systemic immune compartments. The relative
contributions from these two compartments of the immune system are
influenced to a different degree by biological and endocrinological
factors including the menstrual cycle, use of hormonal supplements, local
contraceptives, and infection. Therefore, the long-term objectives of the
proposed studies are to determine the impact of such factors on the origin
and transport of antibodies in female genital tract secretions, and on the
B and T lymphocytes associated with the genital tissues. To address these
considerations, the following specific aims are proposed: 1) to evaluate
the effect of the endogenous and exogenous hormonal status on the immune
system of the genital tract by measuring the levels, isotypes, and
molecular forms of mucosal antibodies in cervical mucus and vaginal
secretions collected from women during their menstrual cycle, in
pregnancy, and in the menopause; 2) to evaluate the effect of local
estrogens, spermicides, and anti-fungal agents on genital tract immunity
in women during their reproductive years before and after treatment with
such agents; and 3) to evaluate the relative contributions of uterine
cervical and vaginal B and T cells and their products to the immune system
of the genital tract before and after specific mucosal immunization. The
accumulated results will provide basic information concerning the
immunology of the female reproductive tract. We will ascertain the
specific effects of hormones and other exogenous agents on immunoglobulin,
cytokine, and secretory component expression and production in the genital
tract. Rational approaches for further studies on the enhancement of
immunity in the genital tract should evolve. The effects of hormonal
therapy, local spermicides, and other factors on the integrity,
enhancement, or suppression of the immune system of the female genital
tract will be addressed in these studies.
女性生殖道的免疫系统由下列成分组成
粘膜(局部)和系统免疫隔间。相对的
来自免疫系统这两个部分的贡献是
不同程度地受到生物学和内分泌学的影响
因素包括月经周期、激素补充剂的使用、局部
避孕药和感染。因此,该计划的长期目标
拟议的研究是为了确定这些因素对起源的影响
和抗体在女性生殖道分泌物中的运输,以及在
与生殖器组织相关的B和T淋巴细胞。要解决这些问题
考虑因素,提出了以下具体目标:1)评价
内源性和外源性激素状态对免疫功能的影响
通过测量水平、同种异型和
宫颈粘液和阴道黏膜抗体的分子形式
从女性月经周期收集的分泌物,在
妊娠及更年期;2)评价局部用药效果
雌激素、杀精剂和抗真菌药物对生殖道免疫的影响
在治疗前后的育龄妇女中,使用
3)评价子宫的相对贡献。
宫颈和阴道B、T细胞及其产物对免疫系统的影响
在特定的粘膜免疫前后生殖道的变化。这个
累积结果将提供有关以下方面的基本信息
女性生殖道免疫学。我们将确定
激素和其他外源性因素对免疫球蛋白的特异性影响,
细胞因子和分泌成分在生殖器中的表达和产生
一条小路。加强生态文明建设进一步研究的理性途径
生殖道中的免疫力应该会进化。荷尔蒙的影响
治疗、局部杀精剂等因素对诚信的影响,
增强或抑制女性生殖器的免疫系统
在这些研究中将涉及到区域。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cervical mucus anti-sperm antibodies: treatment with intrauterine insemination.
宫颈粘液抗精子抗体:宫内授精治疗。
- DOI:10.1111/j.1600-0897.1996.tb00505.x
- 发表时间:1996
- 期刊:
- 影响因子:0
- 作者:Kutteh,WH;Byrd,W;Blankenship,L;Kutteh,CC;Carr,BR
- 通讯作者:Carr,BR
Mucosal immunity in the female reproductive tract: correlation of immunoglobulins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation.
女性生殖道粘膜免疫:排卵前后人类宫颈粘液中免疫球蛋白、细胞因子和生殖激素的相关性。
- DOI:
- 发表时间:1998
- 期刊:
- 影响因子:0
- 作者:Kutteh,WH;Moldoveanu,Z;Mestecky,J
- 通讯作者:Mestecky,J
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM H KUTTEH其他文献
WILLIAM H KUTTEH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM H KUTTEH', 18)}}的其他基金
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% WITH PLACEBO IN THE TREATMENT OF RSA
免疫%20球蛋白%20静脉%20(人类)%2010%%20WITH%20PLACEBO%20IN%20THE%20TREATMENT%20OF%20RSA
- 批准号:
7375413 - 财政年份:2005
- 资助金额:
$ 16.25万 - 项目类别:
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10% WITH PLACEBO IN THE TREATMENT OF RSA
免疫%20球蛋白%20静脉%20(人类)%2010%%20WITH%20PLACEBO%20IN%20THE%20TREATMENT%20OF%20RSA
- 批准号:
7206662 - 财政年份:2004
- 资助金额:
$ 16.25万 - 项目类别:
Immune Globulin Intravenous (Human) 10% with Placebo in the Treatment of RSA
免疫%20球蛋白%20静脉%20(人)%2010%%20与%20安慰剂%20在%20%20治疗%20的%20RSA中
- 批准号:
7041741 - 财政年份:2003
- 资助金额:
$ 16.25万 - 项目类别:
MUCOSAL STRATEGIES FOR GENERAL IMMUNITY AGAINST SEXUALLY TRANSMITTED DISEASE
针对性传播疾病的一般免疫的粘膜策略
- 批准号:
6306306 - 财政年份:1999
- 资助金额:
$ 16.25万 - 项目类别:
MUCOSAL STRATEGIES FOR GENERAL IMMUNITY AGAINST SEXUALLY TRANSMITTED DISEASE
针对性传播疾病的一般免疫的粘膜策略
- 批准号:
6219758 - 财政年份:1999
- 资助金额:
$ 16.25万 - 项目类别:
MUCOSAL STRATEGIES FOR GENERAL IMMUNITY AGAINST SEXUALLY TRANSMITTED DISEASE
针对性传播疾病的一般免疫的粘膜策略
- 批准号:
6116836 - 财政年份:1996
- 资助金额:
$ 16.25万 - 项目类别:
VAGINAL IMMUNITY ROLE OF ENDOGENOUS/EXOGENOUS AGENTS
内源性/外源性物质的阴道免疫作用
- 批准号:
2206563 - 财政年份:1995
- 资助金额:
$ 16.25万 - 项目类别:
VAGINAL IMMUNITY ROLE OF ENDOGENOUS/EXOGENOUS AGENTS
内源性/外源性物质的阴道免疫作用
- 批准号:
2206564 - 财政年份:1995
- 资助金额:
$ 16.25万 - 项目类别:
VAGINAL IMMUNITY ROLE OF ENDOGENOUS/EXOGENOUS AGENTS
内源性/外源性物质的阴道免疫作用
- 批准号:
2206562 - 财政年份:1995
- 资助金额:
$ 16.25万 - 项目类别:
相似海外基金
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9981001 - 财政年份:2017
- 资助金额:
$ 16.25万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9751102 - 财政年份:2017
- 资助金额:
$ 16.25万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
9397073 - 财政年份:2017
- 资助金额:
$ 16.25万 - 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
- 批准号:
10223410 - 财政年份:2017
- 资助金额:
$ 16.25万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
- 批准号:
7951676 - 财政年份:2008
- 资助金额:
$ 16.25万 - 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
- 批准号:
7606036 - 财政年份:2006
- 资助金额:
$ 16.25万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7375053 - 财政年份:2005
- 资助金额:
$ 16.25万 - 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
- 批准号:
7201220 - 财政年份:2004
- 资助金额:
$ 16.25万 - 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
- 批准号:
6980810 - 财政年份:2003
- 资助金额:
$ 16.25万 - 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
- 批准号:
6419444 - 财政年份:2000
- 资助金额:
$ 16.25万 - 项目类别: